Abiopharma

Clinical trial NCT07700225: start date: 2026-07-01 → 2026-08-01.

Clinical trial NCT05261399 updates: 1. primary completion date: 2026-06-18 → 2026-07-06 2. enrollment: 345 → 341 participants

Clinical trial NCT06461897 updates: 1. completion date: 2029-11-01 → 2030-07-01 2. primary completion date: 2029-11-01 → 2030-07-01

Clinical trial NCT06700148 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-08-30 → 2025-07-16 3. primary completion date: 2025-08-30 → 2025-02-19

Clinical trial NCT07504601: start date: 2026-08-10 → 2026-08-11.

Clinical trial NCT07575269: start date: 2026-07-20 → 2026-07-07.

Clinical trial NCT00777582: completion date: 2026-03-31 → 2027-03-31.

Clinical trial NCT07518329: start date: 2026-04-01 → 2026-08-20.

Clinical trial NCT07435194: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT03924050 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-08-08 → 2025-02-24 3. primary completion date: 2023-07-17 → 2024-10-21 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05039840 updates: 1. completion date: 2026-10-02 → 2026-11-24 2. primary completion date: 2026-07-10 → 2026-09-03

Clinical trial NCT06456463 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 83 → 85 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07549490: start date: 2026-08-10 → 2026-08-11.

Clinical trial NCT06617429: primary completion date: 2026-07-01 → 2026-07-10.

Clinical trial NCT05400382 updates: 1. status: UNKNOWN → RECRUITING 2. start date: 2023-07-01 → 2025-12-01 3. completion date: 2026-03-31 → 2028-03-31 4. primary completion date: 2026-03-31 → 2028-03-31 5. primary purpose: TREATMENT → PREVENTION 6. collaborators added: University of Utah 7. collaborators removed: University of Pittsburgh Medical Center, Northwestern University …